Bulk tarpeyo

Ended Awarded Last action

Contract number
36C26025F0063
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cary, NC 27513, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 -$261,528
Funding Only Action P00001 · Bulk tarpeyo - updated 2025 pricing. $6,229
Original award $255,298

About this award

The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company, for the provision of TARPEYO, a specialized medication used to treat primary immunoglobulin A nephropathy, a serious renal condition affecting veterans. This $261,527.52 firm fixed-price contract, which does not have a set-aside designation, is a delivery order against Calliditas Therapeutics' existing Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The contract has an ultimate completion date of March 11, 2026. Calliditas Therapeutics US Inc. has also been awarded multiple Blanket Purchase Agreements (BPAs) by the VA, totaling $5.25 million, to streamline the ordering process and designate the company as the sole approved supplier of TARPEYO to VA medical facilities nationwide.

Quick answers

Who was awarded contract 36C26025F0063?

36C26025F0063 was awarded to Calliditas Therapeutics US Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 12, 2025.

How much is contract 36C26025F0063 worth?

The government has obligated $0 on 36C26025F0063.

Is contract 36C26025F0063 an order under another contract?

Yes. 36C26025F0063 is a delivery order under 36F79722D0153, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26025F0063 competed?

The extent of competition for 36C26025F0063 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award